Apexigen, Inc. Common Stock
APGN
APGN was delisted on the 22nd of August, 2023.
18 hedge funds and large institutions have $8.52M invested in Apexigen, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 24 closing their positions.
11% more call options, than puts
Call options by funds: $50K | Put options by funds: $45K
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
33% less funds holding
Funds holding: 27 → 18 (-9)
38% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 24
77% less capital invested
Capital invested by funds: $37.5M → $8.52M (-$28.9M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCMIC
Decheng Capital Management III (Cayman)
Grand Cayman,
Cayman Islands
|
+$15.4M |
| 2 |
YF
Yu Fan
|
+$3.27M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.09M |
| 4 |
BlackRock
New York
|
+$1.74M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.46M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MSU
Mizuho Securities USA
New York
|
-$4.71M |
| 2 |
MC
Meteora Capital
Boca Raton,
Florida
|
-$4.2M |
| 3 |
KIM
Karpus Investment Management
Pittsford,
New York
|
-$3.72M |
| 4 |
CAC
Cowen and Company
New York
|
-$3.05M |
| 5 |
GCL
Glazer Capital LLC
New York
|
-$2.75M |
APGN Hedge Fund Activity: Q3 2022 in Review
18 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Apexigen, Inc. Common Stock (APGN) for Q3 2022, worth a combined $8.52M — down 77% from $37.5M a quarter earlier.
Sellers outnumbered buyers: 24 funds closed out of APGN and 15 opened new positions — a net loss of 9 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was Decheng Capital Management III (Cayman), opening a new position worth an estimated $15.4M. The largest seller was Mizuho Securities USA, exiting entirely with an estimated $4.71M sold.
- 18 institutional investors held Apexigen, Inc. Common Stock (APGN) as of Q3 2022, down from 27 in Q2 2022.
- Funds reported $8.52M of Apexigen, Inc. Common Stock stock for Q3 2022, down 77% quarter-over-quarter.
- 15 funds opened new Apexigen, Inc. Common Stock positions in Q3 2022 and 24 closed out, a net change of -9 holders.
- The largest Apexigen, Inc. Common Stock buyer in Q3 2022 was Decheng Capital Management III (Cayman), an estimated $15.4M added.
- The largest Apexigen, Inc. Common Stock seller in Q3 2022 was Mizuho Securities USA, an estimated $4.71M sold.
Based on aggregated 13F filings for Q3 2022.